Skip to content

Madrigal Pharmaceuticals, Inc. MDGL Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Jefferies Financial Group logo
Jefferies Financial GroupJEF
17.5K
VICI Properties Inc. logo
VICI Properties Inc.VICI
1.4B0.0%
The Travelers Companies logo
The Travelers CompaniesTRV
1.8B0.0%
EastGroup Properties logo
EastGroup PropertiesEGP
30M0.0%
The Travelers Companies logo
The Travelers CompaniesTRV
1.7B0.0%
Stifel Financial logo
Stifel FinancialSF
3

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized?
Madrigal Pharmaceuticals, Inc. (MDGL) reported preferred stock, shares authorized of $5M in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized?
Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.